Finally, the role of GLP-1 receptor agonists as a possible treatment option in obesity is discussed as well as the role of GLP-1 in the effects of bariatric surgery on adiposity and glucose homeostasis
Results showed that tirzepatide reduced the odds for all observed cardiometabolic abnormalities, including a 34% reduction in odds for decreased HDL-C, 72% reduction for MetS
General medical consultation: If you have any chronic health conditions or take prescription medications, discussing supplement use with your healthcare provider is always advisable before beginning any new product
We can't dictate what they do, but they have other options for what their manufacturing, 'cause they've done the studies, they have to determine that that interaction between B6 or carnitine or B12 doesn't interfere with the the GLP-1 drug
The mechanisms potentially contributing to cardiovascular protection may include effects on weight, glycemic control, blood pressure, and possibly direct effects on vascular inflammation and lipid metabolism, though these mechanisms remain under investigation
